154 related articles for article (PubMed ID: 11982649)
1. Cutaneous HSV-2 infection with serial recurrences at multiple sites.
Dacko A; Don PC; Weinberg JM
Int J Dermatol; 2002 Feb; 41(2):109-11. PubMed ID: 11982649
[No Abstract] [Full Text] [Related]
2. Persistent cutaneous neonatal herpes caused by Herpes simplex virus-2.
Imafuku S; Ohta E; Yoshimura K; Yasumoto S; Hirose S; Nakayama J
J Dermatol; 2012 Jul; 39(7):671-2. PubMed ID: 21955135
[No Abstract] [Full Text] [Related]
3. A missed point in deciphering the viral synergy between herpes simplex virus and HIV.
Lisco A; Vanpouille C; Margolis L
Lancet Infect Dis; 2009 Sep; 9(9):522-3. PubMed ID: 19695487
[No Abstract] [Full Text] [Related]
4. Successful treatment of generalized primary herpes simplex type 2 infection during pregnancy.
Anderson R; Lundqvist A; Bergström T
Scand J Infect Dis; 1999; 31(2):201-2. PubMed ID: 10447333
[TBL] [Abstract][Full Text] [Related]
5. Time to refocus on HSV interventions for HIV prevention?
Tanton C; Abu-Raddad LJ; Weiss HA
J Infect Dis; 2011 Dec; 204(12):1822-6. PubMed ID: 21998480
[No Abstract] [Full Text] [Related]
6. Herpes simplex virus 2 meningitis: a retrospective cohort study.
Miller S; Mateen FJ; Aksamit AJ
J Neurovirol; 2013 Apr; 19(2):166-71. PubMed ID: 23494382
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
8. Fulminant hepatic failure secondary to acyclovir-resistant herpes simplex virus.
Shahani L
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27754940
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
10. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M;
Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966
[TBL] [Abstract][Full Text] [Related]
11. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
12. HSV therapy and HIV-1 reduction.
Martinez V; Caumes E
N Engl J Med; 2007 May; 356(22):2323; author reply 2324. PubMed ID: 17538093
[No Abstract] [Full Text] [Related]
13. Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Brown TJ; McCrary M; Tyring SK
J Am Acad Dermatol; 2002 Oct; 47(4):581-99. PubMed ID: 12271305
[TBL] [Abstract][Full Text] [Related]
14. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
Beeson WH; Rachel JD
Dermatol Surg; 2002 Apr; 28(4):331-6. PubMed ID: 11966791
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir versus valacyclovir.
Rajalakshmi R; Kumari R; Thappa DM
Indian J Dermatol Venereol Leprol; 2010; 76(4):439-44. PubMed ID: 20657140
[No Abstract] [Full Text] [Related]
16. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
17. Oral valacyclovir in the treatment of acute retinal necrosis syndrome.
Aslanides IM; De Souza S; Wong DT; Giavedoni LR; Altomare F; Detorakis ET; Kymionis GD; Pallikaris IG
Retina; 2002 Jun; 22(3):352-4. PubMed ID: 12055471
[No Abstract] [Full Text] [Related]
18. Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir.
Roxby AC; Liu AY; Drake AL; Kiarie JN; Richardson B; Lohman-Payne BL; John-Stewart GC; Wald A; De Rosa S; Farquhar C
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):94-8. PubMed ID: 22852760
[TBL] [Abstract][Full Text] [Related]
19. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
20. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
